First of its kind daily HIV treatment shows promising results
Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for the potential of widespread ...
Feb 9, 2026
0
1









